MDC Rat

Macrophage-Derived Chemokine (CCL22) Rat Recombinant
Shipped with Ice Packs
In Stock

Description

MDC as an Institutional Reference

The Max Delbrück Center (MDC), a leading biomedical research institute in Berlin, has conducted groundbreaking studies on naked mole-rats (Heterocephalus glaber), not conventional laboratory rats. These studies focus on understanding the rodents' exceptional longevity, cancer resistance, and metabolic adaptations to hypoxia. Key findings include:

Metabolic Adaptations in Hypoxia

Naked mole-rats switch from glucose to fructose metabolism during oxygen deprivation, enabling their organs to function longer under hypoxic conditions. For example:

ConditionNaked Mole-RatMouse
Oxygen deprivationSurvives >20 minsBrain damage after 1 min
Energy substrateFructoseGlucose
Organ performanceSynaptic signaling after 1 hourRapid decline

This adaptation is hypothesized to contribute to their resistance to cardiovascular diseases and cancer .

Rat Models in Biomedical Research

While "MDC Rat" is not a defined model, laboratory rats remain critical in biomedical studies. Below are key insights into rat models and their applications:

Genetically Heterogeneous Rat Models

The OKC-HETB/W rat (Brown Norway, Fischer 344, Lewis, Wistar Kyoto) is a 4-way cross model designed to mimic human genetic diversity. Its features include:

CharacteristicOKC-HETB/WTraditional Rat Strains
Genetic diversityHigh (4 inbred strains)Low (inbred)
Mitochondrial genomesBN or WKYHomogeneous
Metabolic responsesDivergent (HFD-induced)Consistent

This model enables studies on complex diseases like obesity and cardiovascular disorders .

Rat Resource & Research Center (RRRC)

The RRRC at the University of Missouri serves as a repository for rat strains, providing:

  • Cryopreservation of embryos and sperm.

  • Distribution of pathogen-free rats globally.

  • Genotyping and infectious disease monitoring .

Potential Misinterpretations

The term "MDC Rat" may stem from conflating:

  1. MDC (Chemical): Dichloromethane (DCM), a solvent with toxicological relevance (e.g., oral rat LD50: 1.25–2 g/kg) .

  2. MDC (Institution): The Max Delbrück Center, which studies naked mole-rats, not laboratory rats.

Research Gaps and Recommendations

  • Citation Analysis of Rat Models: Studies on rat models for depression (e.g., adjuvant arthritis) show limited clinical translation, with only 9.1% of citations from human medical papers .

  • Ethical Considerations: Naked mole-rat studies adhere to strict ethical guidelines, minimizing animal use and suffering .

Product Specs

Introduction
Macrophage-derived chemokine (MDC), also known as CCL22, is a small cytokine belonging to the CC chemokine family. The gene encoding CCL22 is located on chromosome 16 among a cluster of other CC chemokine genes. MDC exhibits chemotactic activity towards various immune cells, including natural killer (NK) cells, chronically activated T lymphocytes, monocytes, and dendritic cells. While it demonstrates mild activity towards primary activated T lymphocytes, it does not attract neutrophils, eosinophils, or resting T lymphocytes. MDC is believed to play a role in directing activated T lymphocytes to sites of inflammation and influencing other aspects of their physiology. It exerts its effects by binding to the cell surface chemokine receptor CCR4. CCL22 is predominantly expressed in macrophages, monocyte-derived dendritic cells, and the thymus. It is also found in lymph nodes, the appendix, activated monocytes, and resting and activated macrophages. Lower levels of CCL22 expression are detected in the lungs and spleen, with very weak expression observed in the small intestine. Within lymph nodes, CCL22 expression is localized to a mature subset of Langerhans cells characterized by the surface markers CD1a+ and CD83+. Elevated expression of CCL22 has been observed in various inflammatory skin conditions, including atopic dermatitis, allergic contact dermatitis, and psoriasis, affecting both the epidermis and dermis. Furthermore, CCL22 is thought to play a role in inhibiting the progression of lung cancer. Notably, a significant increase in CCL22 expression has been linked to gastric cancer.
Description
Recombinant Rat CCL22, produced in E. coli, is a non-glycosylated polypeptide chain consisting of 68 amino acids. It has a molecular weight of 7.9 kDa. The purification process for Rat CCL22 involves proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation
The protein was lyophilized from a 0.2 μm filtered solution in 1xPBS, pH 7.4.
Solubility
It is recommended to reconstitute the lyophilized MDC in sterile 18 MΩ-cm H₂O at a concentration of not less than 100 μg/ml. This solution can then be further diluted in other aqueous solutions.
Stability
Lyophilized MDC, though stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution, MDC should be stored at 4°C for 2-7 days and below -18°C for future use. For long-term storage, adding a carrier protein (0.1% HSA or BSA) is recommended. Avoid repeated freeze-thaw cycles.
Purity
Greater than 97.0% as determined by (a) RP-HPLC analysis and (b) SDS-PAGE analysis.
Biological Activity
The biological activity of CCL22 is determined by its ability to induce chemotaxis in human activated lymphocytes. This is measured using a concentration range of 10.0-100.0 ng/ml.
Synonyms
C-C motif chemokine 22, Small-inducible cytokine A22, Macrophage-derived chemokine, MDC(1-69), Stimulated T-cell chemotactic protein 1, CC chemokine STCP-1, CCL22, MDC, SCYA22, ABCD-1, DC/B-CK, MGC34554, A-152E5.1, CC chemokine ABCD-1, Activated B and dendritic cell-derived, DCBCK.
Source
Escherichia Coli.
Amino Acid Sequence
GPYGANVEDS ICCQDYIRHP LPPRFVKEFY WTSKSCRKPG VVLITIKNRD ICADPRMLWV KKILHKLA.

Q&A

What are MDC proteins and what is their significance in rat models?

MDC proteins comprise a family of cysteine-rich membrane proteins containing metalloproteinase-like and disintegrin-like domains identified in mammalian tissues. These sequence-related proteins have been cloned and analyzed in rat models, with some expressed exclusively in male reproductive tissues while others demonstrate broader tissue distribution . Understanding these proteins provides fundamental knowledge for establishing their individual functions in biological processes and potentially translating findings to human applications.

Which rat strains are recommended for MDC-related research?

Sprague-Dawley (SD) rats are widely recommended for MDC and related research based on their adequate sensitivity, extensive history in research studies, and endorsement by organizations such as the OECD and NTP. These rats are accepted as human-equivalent models for cancer research and meet essential requirements for reproductive toxicity studies including acceptable fecundity rates, low incidence of spontaneous developmental defects, and sufficient survival rates for long-term investigations . For specific experiments focusing on pain sensitivity or other specialized research, African mole-rat species may offer unique advantages due to their special physiological adaptations .

How is rat macrophage-derived chemokine (MDC) typically detected and measured?

Rat macrophage-derived chemokine is commonly measured using ELISA (Enzyme-Linked Immunosorbent Assay) kits specifically designed for this purpose . These assays provide quantitative measurements of MDC concentration in various biological samples from rats. For more precise molecular analysis, researchers may employ state-of-the-art DNA sequencing technology to compare the activity of genes related to MDC expression in different tissues. This approach allows for comprehensive assessment of approximately 7,000 genes within sensory tissues such as spinal cord and spinal ganglions .

How can researchers design integrated protocols to assess multiple toxicological endpoints in MDC rat studies?

An effective integrated study design follows a stepwise process that incorporates priority endpoints from established guidelines on carcinogenicity, chronic toxicity, and developmental and reproductive toxicity. This approach optimizes animal use according to the 3Rs principle (replacement, reduction, refinement) . Implementation involves:

  • Starting with a generational cohort of rats for long-term outcome evaluations

  • Running parallel satellite experiments to measure biomarkers and system-specific responses

  • Including prenatal, lactational, and neonatal exposure periods

  • Evaluating outcomes across the entire lifespan

  • Monitoring metabolic alterations and endocrine disturbances through specific biomarkers

This comprehensive design provides sufficient data on multiple windows of susceptibility relevant for risk assessments and public health decision-making .

What are the key considerations for functional connectivity analysis in rat brain research?

Functional connectivity analysis in rat brains requires standardized acquisition and processing protocols to ensure comparability across research centers. The "StandardRat" consensus protocol was developed after analyzing 65 functional imaging datasets from 46 centers to optimize acquisition parameters . Key considerations include:

  • Implementing reproducible pipelines for analyzing rat data acquired with diverse protocols

  • Determining experimental and processing parameters that enable robust detection of functional connectivity across research centers

  • Utilizing standardized protocols that enhance biologically plausible functional connectivity patterns

  • Ensuring interoperability through openly shared protocols and processing pipelines

This standardized approach significantly improves the detection of functional connectivity patterns compared to previous acquisition methods .

How can researchers study communication patterns in social rat species?

When investigating communication patterns in social rat species, particularly in mole-rats, researchers should employ specialized recording techniques to capture vocalizations and analyze them for dialect features. Studies have revealed that colonies of naked mole-rats develop unique dialects specific to their colony, demonstrating linguistic culture . Research methodologies should include:

  • Recording and cataloging chirping, squeaking, twittering, and grunting vocalizations

  • Analyzing acoustic patterns to identify colony-specific communication features

  • Studying vocalization development within colonies over time

  • Comparing communication patterns across different colonies to establish dialect differences

  • Correlating communication behaviors with social structures and hierarchies

These approaches have revealed remarkable similarities between human and naked mole-rat communication skills, suggesting convergent evolution of linguistic culture .

What is the recommended protocol for voluntary oral dosing in rats for MDC-related research?

Voluntary oral dosing represents a refined alternative to invasive injection methods for administering experimental compounds to rats. A validated protocol for this approach includes :

  • Initial training phase (2 days):

    • Day 1: Introduce rats to a 10% sucrose solution in water via 1mL syringe

    • Day 2: Continue training with rats learning to consume solution from syringe

  • Concentration reduction phase:

    • Gradually reduce sucrose concentration by half each day (10% → 5% → 2.5%)

    • Assess compliance daily (rat consuming 2.0 ml/kg of assigned solution)

  • Transition to experimental compounds:

    • Challenge compliant rats with vehicle solution (MediDrop Sucralose)

    • For non-compliant rats, return to higher concentration before re-challenging

  • Administration of experimental compounds:

    • Mix compounds (e.g., L-DOPA/carbidopa) with artificially sweetened water-based mixture

    • Administer consistently at the same time daily

    • Monitor consumption to ensure complete dosing

This method has been validated for chronically administering compounds that require precise dosing while minimizing stress and improving animal welfare .

How should researchers evaluate tissue distribution of MDC proteins in rat models?

Evaluation of tissue distribution of MDC proteins in rats should follow a systematic approach that accounts for developmental stages and sex differences :

  • Collect diverse tissue samples including reproductive tract, brain, liver, kidney, and other relevant tissues

  • Prepare tissue homogenates and extract proteins using appropriate buffers

  • Analyze protein expression using immunoblotting techniques with specific antibodies

  • Compare expression patterns between:

    • Prepubertal and adult rat tissues

    • Male and female specimens

    • Different regions within the same organ system

This comprehensive assessment provides necessary foundational data for understanding the physiological roles of MDC proteins and forms a critical prelude to functional studies .

What are the validated methods for analyzing plasma levels of compounds in MDC rat studies?

For accurate analysis of plasma levels of experimental compounds in rats, high-performance liquid chromatography (HPLC) with appropriate sample preparation is recommended. The validated protocol includes :

  • Sample collection:

    • Anesthetize rats with isoflurane (5% induction, 1% maintenance)

    • Draw blood (approximately 180 μL) from lateral tail vein into EDTA-coated tubes

    • Add perchloric acid (0.1 N, 20 μL) immediately to stabilize compounds

  • Sample processing:

    • Centrifuge blood at 10,000 ×g

    • Collect supernatant for HPLC assessment

    • Process protein pellets using BCA assay for total protein quantification

  • Data normalization:

    • Normalize monoamine levels to total protein concentration

    • Account for variability in tissue size collected from each rat

This methodology has been successfully used to compare plasma levels of compounds administered through different routes (oral vs. intraperitoneal) and to establish dose-response relationships .

How can MDC-related research in rats contribute to pain management therapeutics for humans?

Research on African mole-rats has revealed unique pain insensitivity that could inform novel human pain management approaches . Key research strategies include:

  • Comparative species analysis:

    • Study multiple mole-rat species with varying pain sensitivities

    • Test responses to different pain stimuli (acid, capsaicin, AICT)

    • Identify species with specific pain insensitivities

  • Molecular investigation:

    • Extract sensory tissue from spinal cord and spinal ganglions

    • Utilize DNA sequencing to compare gene activity (approximately 7,000 genes)

    • Focus on ion channels with altered activity in pain-insensitive animals

  • Therapeutic target identification:

    • Investigate ion channels TRPA1 and NaV1.7, which show altered activity in pain-insensitive species

    • Develop compounds that modulate these channels

    • Test potential analgesic effects in appropriate models

This approach has already identified specific molecular targets that could lead to novel pain management strategies for humans .

What experimental designs are most appropriate for studying developmental toxicity in MDC rat models?

For developmental toxicity studies, an integrated experimental design approach is most effective. The recommended design includes :

  • Multi-generational exposure assessment:

    • Expose rats during key developmental windows (prenatal, lactational, neonatal)

    • Monitor outcomes throughout the entire lifespan

    • Track carcinogenicity, chronic toxicity, and reproductive effects simultaneously

  • Satellite studies within the main experiment:

    • Conduct parallel assessments of biomarkers

    • Measure system-specific responses

    • Evaluate metabolic alterations and endocrine disruptions

  • Comprehensive endpoint evaluation:

    • Incorporate priority endpoints from OECD and NTP guidelines

    • Assess developmental, reproductive, and chronic toxicity parameters

    • Evaluate carcinogenic potential through histopathological examination

This integrated approach maximizes data collection while minimizing animal use, providing comprehensive information about multiple toxicological endpoints in a single study design .

How should researchers address non-compliance in voluntary oral dosing protocols for rats?

When encountering non-compliance during voluntary oral dosing protocols, researchers should implement the following strategies :

  • Return temporarily to higher sucrose concentrations to reinforce positive association

  • Record non-compliance for that day and offer a higher concentration solution

  • Re-challenge with the lower concentration solution later the same day

  • For persistent non-compliance, consider isolating rats from cage mates during training if competition is observed

  • Ensure consistent timing of dosing to establish routine

  • Monitor environmental factors that might affect compliance

This stepwise approach has been shown to effectively overcome non-compliance issues in voluntary oral dosing protocols .

What factors might contribute to variability in MDC protein expression across different rat studies?

Variability in MDC protein expression across different studies may stem from several factors that researchers should consider when interpreting results :

  • Developmental stage: Expression patterns differ significantly between prepubertal and adult rats

  • Sex differences: Some MDC proteins show sex-specific expression, particularly in reproductive tissues

  • Strain variations: Different rat strains may exhibit baseline differences in MDC expression profiles

  • Environmental conditions: Housing, diet, and stress levels can modulate protein expression

  • Tissue collection and processing methods: Variations in sample handling can affect protein stability

  • Detection techniques: Sensitivity and specificity of antibodies used for detection

  • Circadian fluctuations: Timing of sample collection relative to circadian rhythms

Controlling for these variables and providing detailed methodological reporting are essential for meaningful cross-study comparisons .

Product Science Overview

Introduction

Macrophage-Derived Chemokine (CCL22), also known as MDC, is a member of the CC chemokine family. Chemokines are small cytokines or signaling proteins secreted by cells, and they play a crucial role in immune responses by directing the migration of immune cells to sites of inflammation, infection, and trauma. CCL22 is encoded by the CCL22 gene and is highly conserved across species, including rats and humans.

Gene and Protein Structure

The CCL22 gene is located on chromosome 16 in humans and encodes a protein that shares 37% identity with CCL17 at the amino acid level . The recombinant rat CCL22 is a single, non-glycosylated polypeptide chain consisting of 68 amino acids with a molecular weight of approximately 7.9 kDa . The amino acid sequence of rat CCL22 is as follows: GPYGANVEDS ICCQDYIRHP LPPRFVKEFY WTSKSCRKPG VVLITIKNRD ICADPRMLWV KKILHKLA .

Expression and Secretion

CCL22 is predominantly expressed in macrophages, monocyte-derived dendritic cells, and the thymus . It is also detected in tissues such as the lymph nodes and appendix . Upon secretion from monocyte-derived dendritic cells, CCL22 can be proteolytically cleaved into three forms: MDC (3-69), MDC (5-69), and MDC (7-69) .

Biological Activity

CCL22 exerts its effects by binding to the CCR4 receptor . It acts as a chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer (NK) cells, but not for neutrophils, eosinophils, or resting T-lymphocytes . Additionally, CCL22 has been shown to have HIV suppressive activity . The biological activity of recombinant rat CCL22 is confirmed through chemotaxis bioassays using human T-lymphocytes, with effective concentrations ranging from 10 to 100 ng/ml .

Applications and Usage

Recombinant rat CCL22 is widely used in research to study immune responses, cell signaling, and chemokine-receptor interactions. It is available in lyophilized form and can be reconstituted in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml . The protein is stable for up to 12 months when stored at -20 to -70°C and should be handled under sterile conditions to avoid contamination .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.